Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Form 10-Q Tobira Therapeutics, For: Sep 30
November 10, 2015 4:10 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC... More
Form 8-K Tobira Therapeutics, For: Nov 10
November 10, 2015 4:06 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... More